Cargando…

Targeting multiple epitopes on the spike protein: a new hope for COVID-19 antibody therapy

Detalles Bibliográficos
Autores principales:	Sun, Yeping, Kobe, Bostjan, Qi, Jianxun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501506/ https://www.ncbi.nlm.nih.gov/pubmed/32951007 http://dx.doi.org/10.1038/s41392-020-00320-6

Ejemplares similares

High hopes and high honours for cancer immunotherapy
por: Häfner, Sophia Julia
Publicado: (2019)

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
por: Yang, Yang, et al.
Publicado: (2021)

SARS-CoV-2 spike protein: flexibility as a new target for fighting infection
por: Pierri, Ciro Leonardo
Publicado: (2020)

CD5: from antiquated T cell marker to immunotherapy’s new hope
por: Schwarz, Sandra, et al.
Publicado: (2023)

New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein
por: Wang, Junzhi
Publicado: (2020)

Development of Antibody‐Directed Therapies: Quo Vadis?
por: Rodrigues, Tiago, et al.
Publicado: (2018)

Safety and efficacy of toripalimab in advanced gastric cancer: A new clinical trial bringing hope for immunotherapy in gastric cancer
por: Qiu, Haibo
Publicado: (2020)

Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023)

Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection
por: Kalra, Rajkumar Singh, et al.
Publicado: (2021)

The SARS-CoV-2 spike protein: balancing stability and infectivity
por: Berger, Imre, et al.
Publicado: (2020)

Omicron spike protein: a clue for viral entry and immune evasion
por: Behrens, G. M. N., et al.
Publicado: (2022)

Highlight: Shining New Light on Coral Fluorescent Proteins
por: Venton, Danielle
Publicado: (2017)

SWI/SNF proteins as targets in cancer therapy
por: Schiaffino-Ortega, Santiago, et al.
Publicado: (2014)

Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain
por: Ribes, Marta, et al.
Publicado: (2021)

Spiking the MERS-coronavirus receptor
por: Bosch, Berend Jan, et al.
Publicado: (2013)

New discoveries on how DICER efficiently processes pre‐miRNA
por: Weng, Qi, et al.
Publicado: (2023)

Multi-cancer blood testing combined with PET-CT: road for hope to screen for cancer and guide intervention
por: Jiang, Tao, et al.
Publicado: (2020)

Unraveling the Dynamics of Antibody-Antigen Interaction by DNA Origami
por: Nie, Zhou
Publicado: (2020)

Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes
por: Hurtado, Jonathan, et al.
Publicado: (2023)

Multiple sclerosis: Immunopathological heterogeneity and its implications
por: Engelhardt, Britta, et al.
Publicado: (2022)

Complex Spike Wars: a New Hope
por: Streng, Martha L., et al.
Publicado: (2018)

Breathing new life into an old target: pulmonary disease drugs for Parkinson’s disease therapy
por: Abdelmotilib, Hisham, et al.
Publicado: (2017)

Cold is cool, the human microbiota and taking multiple SIPs
por: Daniels, Craig, et al.
Publicado: (2011)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

SIRT7 slows down stem cell aging by preserving heterochromatin: a perspective on the new discovery
por: Sun, Luyang, et al.
Publicado: (2020)

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
por: Li, Fang, et al.
Publicado: (2020)

Connections between biomechanics and higher infectivity: a tale of the D614G mutation in the SARS-CoV-2 spike protein
por: Mittal, Anshumali, et al.
Publicado: (2021)

On the road to epigenetic therapy
por: Walton, Emma L.
Publicado: (2016)

The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies
por: Yang, Chang, et al.
Publicado: (2021)

Rough operators: sphingomyelinase inhibitors spike NK cells to kill cancer
por: Carlsten, Mattias, et al.
Publicado: (2023)

COVID-19: cross-immunity of viral epitopes may influence severity of infection and immune response
por: Kashir, Junaid, et al.
Publicado: (2021)

Who Has Therapy-Related AML?
por: Gale, Robert Peter, et al.
Publicado: (2017)

Towards gene therapy for IPEX syndrome
por: Borna, Simon, et al.
Publicado: (2022)

New waves underneath the purple strain
por: Tortajada, Marta
Publicado: (2016)

Epstein Barr virus infection and immune defense related to HLA‐DR15: consequences for multiple sclerosis
por: Olsson, Tomas
Publicado: (2020)

Phage display: development of nanocarriers for targeted drug delivery to the brain
por: Bakhshinejad, Babak, et al.
Publicado: (2015)

Metabolic engineering, new antibiotics and biofilm viscoelasticity
por: Daniels, Craig, et al.
Publicado: (2010)

Microbiomes as the new keystone for life sciences development
por: Udaondo, Zulema, et al.
Publicado: (2019)

Antigen targeting to dendritic cells: Still a place in future immunotherapy?
por: Stoitzner, Patrizia, et al.
Publicado: (2022)

Modulating serine palmitoyltransferase‐deoxysphingolipid axis in cancer therapy
por: Xiang, Yuancai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7rr4l2rsljisntqrnp21sm8d7m